Altamira Therapeutics Ltd.: xbrl:ActuarialAssumptionOfDiscountRates
| Value | {"value": 0.003} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/28548134-20a0-49e4-88a4-a52aeff6073a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-22-019292Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/28548134-20a0-49e4-88a4-a52aeff6073a
History
- no predecessors — first report